Clinical trial

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe…

NCT00426647 · Norpharma A/S, Industry · Completed

Key facts

NCT number NCT00426647
Title Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine
Official title A Randomised Double-blind Multicentre Equivalence Study With Active Parallel Comparator Group to Evaluate the Efficacy and Safety of Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip, Knee &/or Lumbar Spine.
Lead sponsor Norpharma A/S, Industry
Collaborators Mundipharma Finland
Status Completed
Phase Phase 4
Study type Interventional
Conditions Osteoarthritis, Pain
Intervention type Drug
Interventions Buprenorphine, Tramadol
Enrollment 120
Start date Feb 1, 2007
Primary completion Jul 1, 2009
Completion Aug 1, 2009
First posted Jan 25, 2007
Last update posted Feb 1, 2010
Countries Finland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies